Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

Background: It remains unclear whether combination antiretroviral therapy (ART) regimens differ in their ability to fully suppress human immunodeficiency virus (HIV) replication. Here, we report the results of two cross-sectional studies that compared levels of cell-associated (CA) HIV markers betwe...

ver descrição completa

Detalhes bibliográficos
Principais autores: Alexander O Pasternak, Jelmer Vroom, Neeltje A Kootstra, Ferdinand WNM Wit, Marijn de Bruin, Davide De Francesco, Margreet Bakker, Caroline A Sabin, Alan Winston, Jan M Prins, Peter Reiss, Ben Berkhout, The Co-morBidity in Relation to Aids (COBRA) Collaboration
Formato: Artigo
Idioma:English
Publicado em: eLife Sciences Publications Ltd 2021-08-01
coleção:eLife
Assuntos:
HIV
virus infection
antiviral drugs
Acesso em linha:https://elifesciences.org/articles/68174

Internet

https://elifesciences.org/articles/68174

Registros relacionados